Aura Biosciences, Inc.AURANASDAQ
Loading
Operating Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+23.1%
5Y CAGR+38.3%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+23.1%/yr
Annual compound
5Y CAGR
+38.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
5.1x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $112.47M | +17.0% |
| 2024 | $96.12M | +14.8% |
| 2023 | $83.70M | +38.8% |
| 2022 | $60.30M | +71.0% |
| 2021 | $35.25M | +58.7% |
| 2020 | $22.21M | -6.0% |
| 2019 | $23.63M | - |